HiTech Health is delighted to partner with VascVersa, a regenerative medicine company developing exciting new cell therapies that promote vascular regeneration and repair. VascVersa is a spin-out of Queen’s University Belfast and built on over 20 years of research. VascVersa’s  ANGICYTE™ Technology provides a revolutionary Cell Therapy for blood vessel regeneration. It stimulates new blood vessel formation leading to improved blood supply & long term healing. This pipeline technology has the potential to be used for a number of ischaemic diseases. The HiTech Health team are excited to work with VascVersa on developing the ANGICYTE™ Technology for use in treating patients.

Learn more about our cell and gene therapy services by clicking here

Find us on LinkedIn

Contact: info@hitech-health.com